This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 6 and 35
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The objective of the study is to evaluate the immunogenicity and safety of prime-boost vaccination schedule of GSK Biologicals' investigational vaccine GSK1562902A.

Provided treatments

  • Biological: GSK Biologicals' investigational vaccine GSK1562902A

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01323946. The sponsor of the trial is GlaxoSmithKline and it is looking for 113 volunteers for the current phase.
Official trial title:
Safety and Immunogenicity of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine (GSK1562902A) in Children Aged 6 to 35 Months